Biden Cancer Initiative Announces Oncology Clinical Trial Information Commons

June 2, 2019

In an effort to allow patients to know their clinical trial options, the Biden Cancer Initiative has announced that 9 healthcare innovators are coming together to form the Oncology Clinical Trial Information Commons.

In an effort to allow patients to know their clinical trial options, the Biden Cancer Initiative has announced that 9 healthcare innovators are coming together to form the Oncology Clinical Trial Information Commons. The shared platform, which will be used to sore information on clinical trials and be accessed for patient matching and other data mining, will employ a single set of terms ad rules and a user-friendly interface for companies to enter and update information, such as patient selection criteria, trial locations, and patient participation requirements.

Founding members of the collaboration include BreastCancerTrials.org, Cancer Commons, Ciitizen, EmergingMed, GenomOncology, Genospace/Sarag Cannon Research Center, IBM Watson Health, Massive Bio, and Syapse.